The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

QR Code

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

Enregistré dans:

Détails bibliographiques
Auteur principal:	Panagiotis F. Christopoulos
Format:	article
Langue:	EN
Publié:	Wiley 2021
Sujets:	cancer vaccines COVID‐19 immunotherapy SARS‐CoV‐2 Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/cd4fe03427214a60b37c579fe3d0d1c4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

SARS‐CoV‐2 infection shortly after BNT162b2 vaccination results in high anti‐spike antibody levels in nursing home residents and staff
par: Doris Urlaub, et autres
Publié: (2021)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity
par: Carlos del Fresno, et autres
Publié: (2021)

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
par: Chih-Yun Lai, et autres
Publié: (2021)

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
par: Piotr Rzymski, et autres
Publié: (2021)

Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
par: Ruby A. Escobedo, et autres
Publié: (2021)

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination
par: Robert Flisiak, et autres
Publié: (2021)

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
par: Julie Demaret, et autres
Publié: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
par: Antonio J. Martín-Galiano, et autres
Publié: (2021)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
par: Yandi Zhang, et autres
Publié: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
par: Felipe Melo-González, et autres
Publié: (2021)

Current and future nanoparticle vaccines for COVID-19
par: Mai N. Vu, et autres
Publié: (2021)

Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
par: Ramesh Kandimalla, et autres
Publié: (2021)

Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants
par: Wei-Shuo Lin, et autres
Publié: (2021)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
par: Jin Wang, et autres
Publié: (2021)

The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
par: Michael F. Good, et autres
Publié: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
par: Shaikh Terkis Islam Pavel, et autres
Publié: (2021)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
par: Dandan Tian, et autres
Publié: (2021)

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
par: Edrous Alamer, et autres
Publié: (2021)

Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost
par: Amar K. Garg, et autres
Publié: (2021)

Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
par: Isabel Iguacel, et autres
Publié: (2021)

Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia
par: Edrous Alamer, et autres
Publié: (2021)

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
par: Ángel Estella, et autres
Publié: (2021)

High‐resolution HLA genotyping identifies alleles associated with severe COVID‐19: A preliminary study from India
par: Ravikanth Vishnubhotla, et autres
Publié: (2021)

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
par: Johnstone Tcheou, et autres
Publié: (2021)

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
par: Kadhim Hayawi, et autres
Publié: (2021)

Immune thrombocytopenia relapse post covid-19 vaccine in young male patient
par: Hana Qasim, et autres
Publié: (2021)

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany’s Largest Public Health Department (Cologne)
par: Lea Hsu, et autres
Publié: (2021)

Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
par: Krzysztof Lukaszuk, et autres
Publié: (2021)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
par: Diego Urrunaga-Pastor, et autres
Publié: (2021)

Development of Inactivated FAKHRAVAC<sup>®</sup> Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
par: Soheil Ghasemi, et autres
Publié: (2021)

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology
par: Jennifer K. DeMarco, et autres
Publié: (2021)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
par: Bruna Aparecida Souza Machado, et autres
Publié: (2021)

The clinical outcomes of COVID‐19 in HIV‐positive patients: A systematic review of current evidence
par: SeyedAhmad SeyedAlinaghi, et autres
Publié: (2021)

COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control
par: Philippe Buchy, et autres
Publié: (2021)

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors
par: Pavla Taborska, et autres
Publié: (2021)

Organisational Model and Coverage of At-Home COVID-19 Vaccination in an Italian Urban Context
par: Elettra Carini, et autres
Publié: (2021)

Investigating Adherence to COVID-19 Vaccination and Serum Antibody Concentration among Hospital Workers—The Experience of an Italian Private Hospital
par: Guglielmo Forgeschi, et autres
Publié: (2021)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
par: Bruno Fattizzo, et autres
Publié: (2021)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
par: Piotr Rzymski, et autres
Publié: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
par: Fuxing Lou, et autres
Publié: (2021)